HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

In-San Kim Selected Research

In-San Kim Research Topics

Disease

112Neoplasms (Cancer)
01/2022 - 10/2002
10Neoplasm Metastasis (Metastasis)
01/2021 - 10/2002
10Breast Neoplasms (Breast Cancer)
11/2020 - 05/2008
10Lung Neoplasms (Lung Cancer)
01/2019 - 09/2003
8Melanoma (Melanoma, Malignant)
10/2021 - 03/2006
6Inflammation (Inflammations)
01/2020 - 10/2003
6Atherosclerotic Plaque (Atheroma)
01/2020 - 06/2008
6Atherosclerosis
01/2020 - 10/2008
4Sepsis (Septicemia)
01/2020 - 04/2014
4Carcinogenesis
10/2017 - 01/2007
4Cadaver (Cadavers)
09/2009 - 04/2008
4Fibrosis (Cirrhosis)
06/2008 - 10/2002
3Thrombosis (Thrombus)
01/2018 - 06/2007
3Urinary Bladder Neoplasms (Bladder Cancer)
10/2016 - 01/2007
3Colonic Neoplasms (Colon Cancer)
02/2015 - 09/2008
3Genetic Predisposition to Disease (Genetic Predisposition)
04/2008 - 10/2003
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2008 - 10/2003
3Hereditary Corneal Dystrophies
10/2007 - 03/2002
3Adenocarcinoma
01/2007 - 10/2003
2Colorectal Neoplasms (Colorectal Cancer)
10/2021 - 01/2021
2Hypoxia (Hypoxemia)
01/2021 - 02/2003
2Pancreatic Neoplasms (Pancreatic Cancer)
11/2020 - 01/2019

Drug/Important Bio-Agent (IBA)

39Peptides (Polypeptides)IBA
10/2021 - 03/2004
23Pharmaceutical PreparationsIBA
10/2021 - 02/2008
23Proteins (Proteins, Gene)FDA Link
01/2021 - 03/2002
21Doxorubicin (Adriamycin)FDA LinkGeneric
10/2021 - 08/2003
12glycol-chitosanIBA
02/2014 - 08/2003
10Transforming Growth Factor beta (TGF-beta)IBA
10/2010 - 03/2002
9Biomarkers (Surrogate Marker)IBA
10/2021 - 10/2003
9ProdrugsIBA
01/2021 - 02/2015
8LigandsIBA
10/2021 - 01/2008
7Ferritins (Ferritin)IBA
10/2021 - 03/2016
7IntegrinsIBA
07/2018 - 01/2008
6CaspasesIBA
10/2021 - 12/2009
6Coloring Agents (Dyes)IBA
01/2019 - 02/2010
6Small Interfering RNA (siRNA)IBA
10/2017 - 02/2008
6Drug CarriersIBA
11/2011 - 09/2006
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 10/2003
5Therapeutic UsesIBA
10/2021 - 02/2008
5Caspase 3 (Caspase-3)IBA
01/2019 - 02/2015
5Interleukin-4 Receptors (Interleukin 4 Receptor)IBA
03/2016 - 10/2008
5Heparin (Liquaemin)FDA LinkGeneric
12/2008 - 09/2006
5Transforming Growth Factor beta1 (TGF beta 1)IBA
05/2007 - 10/2002
4Cisplatin (Platino)FDA LinkGeneric
12/2021 - 04/2008
4Immune Checkpoint InhibitorsIBA
10/2021 - 01/2021
4Antineoplastic Agents (Antineoplastics)IBA
10/2021 - 05/2009
4CytokinesIBA
01/2021 - 07/2010
4Poloxamer (Poloxamer 407)IBA
01/2020 - 07/2015
4Liposomes (Liposome)IBA
01/2019 - 04/2011
4MicellesIBA
10/2017 - 11/2007
4PolymersIBA
10/2017 - 02/2007
4Fibronectins (Fibronectin)IBA
06/2016 - 03/2002
4cysteinyl- glutaminyl- arginyl- prolyl- prolyl- arginineIBA
01/2015 - 12/2010
4PhosphatidylserinesIBA
01/2015 - 09/2008
4Fluorescein (Funduscein)FDA LinkGeneric
11/2008 - 08/2003
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2022 - 08/2004
3Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
01/2022 - 03/2013
3rho-Associated KinasesIBA
11/2021 - 01/2018
3liposomal doxorubicin (Doxil)FDA Link
10/2021 - 04/2011
3Membrane Proteins (Integral Membrane Proteins)IBA
12/2020 - 04/2016
3EnzymesIBA
10/2020 - 11/2011
3AntigensIBA
11/2019 - 10/2003
3CollagenIBA
10/2018 - 10/2007
3DisulfidesIBA
10/2017 - 07/2012
3Deoxycholic Acid (Sodium Deoxycholate)IBA
10/2017 - 02/2008
3Tumor Biomarkers (Tumor Markers)IBA
12/2016 - 01/2016
3KLA peptideIBA
10/2016 - 06/2008
3Angiogenesis InhibitorsIBA
04/2016 - 12/2008
3Messenger RNA (mRNA)IBA
07/2015 - 10/2002
3Hyaluronic Acid (Hyaluronan)IBA
01/2015 - 10/2003
3CamptothecinIBA
01/2015 - 05/2008
3Paclitaxel (Taxol)FDA LinkGeneric
05/2014 - 03/2006
3Histones (Histone)IBA
01/2014 - 12/2010
3Extracellular Matrix ProteinsIBA
02/2012 - 03/2002
32- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
11/2011 - 05/2008
3Fluorescein-5-isothiocyanate (FITC)IBA
10/2011 - 08/2003
3Radioisotopes (Radionuclides)IBA
12/2010 - 02/2007
3ChitosanIBA
09/2010 - 08/2003
3monomethoxypolyethylene glycol (MPEG)IBA
06/2010 - 11/2007
3poly(beta-amino ester)IBA
06/2010 - 11/2007
3Guanosine Diphosphate (GDP)IBA
01/2010 - 10/2003
3Cell Adhesion MoleculesIBA
04/2008 - 03/2002
3Desoxycorticosterone Acetate (DOCA)FDA Link
06/2007 - 09/2006
3Glucose (Dextrose)FDA LinkGeneric
02/2007 - 03/2003
2AcidsIBA
01/2022 - 11/2015
2Biocompatible Materials (Biomaterials)IBA
01/2022 - 08/2011
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
12/2021 - 01/2021
2microplasminIBA
10/2021 - 01/2018
2Apoptosis Regulatory ProteinsIBA
10/2021 - 10/2017
2Hemostatics (Antihemorrhagics)IBA
10/2021 - 01/2018
2Cathepsin BIBA
01/2021 - 02/2014
2AnticoagulantsIBA
01/2021 - 03/2013
2Fluorescent Dyes (Fluorescent Probes)IBA
01/2020 - 12/2010
2Protein CIBA
01/2020 - 11/2015

Therapy/Procedure

49Therapeutics
12/2021 - 10/2003
16Immunotherapy
12/2021 - 09/2012
13Drug Therapy (Chemotherapy)
01/2019 - 02/2007
4Intravenous Injections
10/2020 - 02/2007
4Intravenous Administration
01/2020 - 01/2006
4Radiotherapy
01/2019 - 08/2015